| ||
Teva Pharmaceutical Forms S. Korean Joint Venture (TEVA) Motley Fool Teva Pharmaceutical (NYSE: TEVA ) has entered a business venture with Handok Pharmaceuticals of South Korea. In an effort to gain entrance into the Korean market, which Teva estimates to be $14 billion, it agreed to partner with Handok to market and ... See all stories on this topic » | ||
| ||
COMMISSION ANNOUNCEMENTS - SEC Suspends Trading in the Securities of ... MENAFN.COM Dec 17, 2012 (Menafn - SECURITIES AND EXCHANGE COMMISSION RELEASE/ContentWorks via COMTEX) --The Securities and Exchange Commission (Commission) announced the temporary suspension of trading in the securities of Spencer ... See all stories on this topic » | ||
Daily Options Trading for Teva Pharmaceutical Industries AVAFIN NEW YORK (AVAFIN) -- Teva Pharmaceutical Industries options contracts experienced a new 90-day record for call contracts where a total of 13,065 call contracts were traded in the busy trading session. The contract spread yielded a 0.32 put/call ratio ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment